Skip to content

IMNM

Immunome, Inc.

Stock

$20.90+0.01 (+0.05%)Close Oct 2, 2026

Shareholders' equity, 2025
$634M
YoY, 2025
+250.1%
5-year CAGR
+72.7%

Shareholders' equity

Shareholders' equity by fiscal year

PeriodEquityYoY
2025$634M+250.1%
2024$181M+51.1%
2023$120M+619.9%
2022$17M−65.4%
2021$48M+16.5%
2020$41M—
2019−$36M—